AN2 Therapeutics
ANTX
$1.99
Share price
-2.45%
Change (1 day)
-64.53%
Change (1 year)
Categories
AN2 Therapeutics (ANTX) - Cash on Hand
Cash on Hand as of March 2024 : $0.11 B
According to AN2 Therapeutics's latest financial reports the company has $0.11 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
AN2 Therapeutics - Cash on Hand chart (from 2021 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $96.05 M | 64.05% |
| 2021-12-31 | $58.55 M | 1338.7% |
| 2020-12-31 | $4.07 M |